A detailed history of Wealthcare Advisory Partners LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wealthcare Advisory Partners LLC holds 43,291 shares of ABBV stock, worth $7.14 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
43,291
Previous 43,801 1.16%
Holding current value
$7.14 Million
Previous $7.51 Million 13.8%
% of portfolio
0.25%
Previous 0.24%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$163.84 - $199.33 $83,558 - $101,658
-510 Reduced 1.16%
43,291 $8.55 Million
Q2 2024

Aug 09, 2024

BUY
$154.79 - $180.76 $149,217 - $174,252
964 Added 2.25%
43,801 $7.51 Million
Q1 2024

Apr 15, 2024

BUY
$159.82 - $182.1 $1.31 Million - $1.49 Million
8,184 Added 23.62%
42,837 $7.8 Million
Q4 2023

Feb 06, 2024

BUY
$137.6 - $154.97 $180,806 - $203,630
1,314 Added 3.94%
34,653 $5.37 Million
Q3 2023

Oct 12, 2023

SELL
$133.59 - $154.65 $43,015 - $49,797
-322 Reduced 0.96%
33,339 $4.97 Million
Q2 2023

Jul 17, 2023

SELL
$132.51 - $164.9 $808,973 - $1.01 Million
-6,105 Reduced 15.35%
33,661 $4.54 Million
Q1 2023

May 04, 2023

BUY
$144.61 - $166.54 $84,018 - $96,759
581 Added 1.48%
39,766 $6.34 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $853,649 - $1.02 Million
6,172 Added 18.7%
39,185 $6.34 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $157,965 - $181,175
1,177 Added 3.7%
33,013 $4.43 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $162,253 - $206,277
-1,179 Reduced 3.57%
31,836 $4.88 Million
Q1 2022

Apr 15, 2022

SELL
$131.98 - $163.75 $448,863 - $556,913
-3,401 Reduced 9.34%
33,015 $5.35 Million
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $403,399 - $510,417
-3,755 Reduced 9.35%
36,416 $4.93 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $109,379 - $124,161
1,028 Added 2.63%
40,171 $4.33 Million
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $106,156 - $118,264
-1,009 Reduced 2.51%
39,143 $4.41 Million
Q1 2021

Apr 30, 2021

BUY
$102.3 - $112.62 $1.2 Million - $1.33 Million
11,779 Added 41.51%
40,152 $4.35 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $81,616 - $110,191
1,014 Added 3.71%
28,373 $3.04 Million
Q3 2020

Oct 29, 2020

BUY
$85.91 - $100.83 $157,473 - $184,821
1,833 Added 7.18%
27,359 $2.4 Million
Q2 2020

Jul 29, 2020

BUY
$73.37 - $98.18 $293,480 - $392,720
4,000 Added 18.58%
25,526 $2.51 Million
Q1 2020

Apr 29, 2020

SELL
$64.5 - $97.79 $41,409 - $62,781
-642 Reduced 2.9%
21,526 $1.64 Million
Q4 2019

Jan 29, 2020

BUY
$72.13 - $90.25 $954,352 - $1.19 Million
13,231 Added 148.05%
22,168 $1.96 Million
Q3 2019

Oct 17, 2019

SELL
$62.98 - $75.72 $63,105 - $75,871
-1,002 Reduced 10.08%
8,937 $677,000
Q2 2019

Jul 30, 2019

SELL
$65.7 - $83.98 $33,112 - $42,325
-504 Reduced 4.83%
9,939 $723,000
Q1 2019

May 13, 2019

SELL
$77.14 - $90.79 $595,752 - $701,171
-7,723 Reduced 42.51%
10,443 $842,000
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $38,769 - $47,812
498 Added 2.82%
18,166 $1.68 Million
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $1,333 - $1,482
15 Added 0.08%
17,668 $1.67 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $46,775 - $55,345
521 Added 3.04%
17,653 $1.64 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $215,855 - $289,050
-2,346 Reduced 12.04%
17,132 $1.62 Million
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $36,092 - $39,578
403 Added 2.11%
19,478 $1.88 Million
Q3 2017

Nov 15, 2017

BUY
$69.85 - $89.22 $1.33 Million - $1.7 Million
19,074 Added 1907400.0%
19,075 $1.7 Million
Q2 2017

Aug 29, 2017

BUY
N/A
1
1 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wealthcare Advisory Partners LLC Portfolio

Follow Wealthcare Advisory Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.